Liver Cancer

Hong Kong Institute of Science and Technology has created a new drug for liver cancer, not only can effectively inhibit cancer cell growth, it will not even kill healthy cells. Queen Mary's Hospital will begin using it in clinical practice in patients with end stage liver cancer, and if successful, then the predicted bias marketed in 2007.

Hong Kong Institute of Science and Technology managed to extract some of the bacillus subtilis arginine, which can inhibit cancer cell growth. Relevant experts from the institute said that in March last year had conducted a clinical trial on two late stage liver cancer patients, and the results are quite encouraging as one cancer cell tumor patients became significantly smaller after 6 months of treatment. In contrast, the treatment of other patients is not effective, so the doctor stopped the treatment.

Relevant experts said, that if the final stage liver cancer patients who umumnyahanya can survive for several months, after the age of drug use may be extended for more than 10 months, it was a satisfactory result. Hong Kong Institute of Science and Technology will further cooperate with the Queen Mary Hospital, which is trying the drug in 30 patients, and if successful, this new drug can be marketed in 2007, and gave new hope for patients with end stage liver cancer. Total research had already spent more than 30 million Hong Kong dollars within four years, and earned two awards from the Golden international association of new technologies in Geneva, Switzerland.

Liver cancer by the Hong Kong Department of Health stated sebaga cancer killer-2. And according to statistical data, that from 1986-1996, a total of 12.498 people die from the disease in Hong Kong. On average each year found about 1500 new cases of disease, and every year who died of liver cancer less than about 1300 people. Previous treatments such as liver transplantation, chemotherapy and therapeutic arterial embolis, just get rid of liver cancer cells, but for end-stage patients, the percentage of living is generally no more than ½ year